LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointme…
Category: Business
Samsara Vision Promotes Jason Herod to President and Chief Executive Officer
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision promoted Jason Herod to President and CEO. Having joined Samsara Vision in 2021, Mr. Herod was most recently Chief Commercial Officer.
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced findings from a new survey highlighting a significant awareness ga…
Unum Group to Present at the KBW Insurance Conference
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Unum Group’s (NYSE: UNM) President & CEO, Rick McKenney will represent the company at the KBW Insurance Conference. McKenney is scheduled to speak at the conference at 2:05 p.m. ET on Wednesday, September 9, 202…
Stuart Therapeutics, Inc. Appoints Dave LeCause as Senior Commercial Advisor
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of Dave LeCause as senior comm…
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that two of its pharmaceutical pipeline assets – both first-in-cla…
Bridging Clinical Practice and Drug Development, Ora Appoints Dr. John Trein as Therapeutic Lead, Posterior
BOSTON–(BUSINESS WIRE)– #ClinicalResearch–Ora, the world’s leading ophthalmic contract research organization, appoints retina specialist Dr. John Trein as Therapeutic Lead, Posterior
Stuart Therapeutics, Inc. Appoints David Jakeman as Chief Financial Officer
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics, Inc. (“Stuart”), a clinical-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of David Jakeman as chief …
Ingenia Therapeutics Goes Public on KOSDAQ to Accelerate Pipeline of Next-Generation Vascular Antibody Therapeutics
WATERTOWN, Mass.–(BUSINESS WIRE)–Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced today that its shares have begun trading on the KOSDAQ market. The IPO marks a significant…
Experiences That Matter Foundation Receives the SBB Research Group Foundation Grant
CHICAGO–(BUSINESS WIRE)–Experiences That Matter Foundation received a $5,000 grant from the SBB Research Group Foundation, which awards monthly grants to support impactful organizations. Experiences That Matter Foundation, based in Chicago, Illinois,…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe
BOLOGNA, Italy & MILAN, Italy–(BUSINESS WIRE)–Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, today announced that it has entered into a share purchase agreement with SEVER Life Sciences B.V. (“SEVER”) for the sale of 100% of the sha…
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
ForSight Robotics Demonstrates Fully Robotic-Assisted Cataract Surgery Within the Standard Clinical Workflow of the World's Most Commonly Performed Surgical Procedure
CAESAREA, Israel–(BUSINESS WIRE)–ForSight Robotics, a global pioneer in robotic eye surgery, today announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract surgery can be s…
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
BENGALURU, India & BRIDGEWATER, N.J.–(BUSINESS WIRE)– #biosimilar–Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg, Used to Treat Various Types of Ophthalmology Conditions